Board of Directors

The ITOG Board of Directors provides strategic leadership and governance to advance the organization’s mission. Through scientific expertise, collaboration, and long-term vision, the Board helps guide ITOG’s priorities, strengthen organizational integrity, and support meaningful impact in thyroid cancer research and care.

Gregory W. Randolph
Gregory W. Randolph MD, FACS, FACE
Harvard Medical School
Mass Eye and Ear

President

Laura Boucai, MD
Laura Boucai, MD 

Memorial Sloan Kettering

Secretary

Frank Worden, MD
Frank Worden, MD 

University of Michigan

Protocol Committee Chair

Alan Ho, MD, PhD
Alan Ho, MD, PhD 

Memorial Sloan Kettering

Correlative Science Committee Chair

Carmelo Nucera, MD,
Carmelo Nucera, MD,PhD
Beth Israel Deaconess Medical Center
Harvard Medical School

Website & Communications Committee

Naifa Busaidy, MD
Naifa Busaidy, MD 

MD Anderson Cancer Center

Membership Committee Chair

Ian Ganly, MD, PhD
Ian Ganly, MD, PhD 
Memorial Sloan Kettering

Member at Large

Lindsay Bischoff, MD
Lindsay Bischoff, MD 
Vanderbilt University Medical Center

Publications Committee Chair

Laura Fugazzola, MD
Laura Fugazzola, MD 
University of Milan

International Member Seat

Sarimar N. Agosto Salgado, MD
Sarimar N. Agosto Salgado, MD

Moffitt Cancer Center

Education Committee Chair

Robert Gagel, MD
Robert Gagel, MD 

MD Anderson Cancer Center

Finance Committee Chair

Theodora Pappa, MD, PhD
Theodora Pappa, MD, PhD
Brigham and Women’s Hospital / Harvard

Member at Large

Victor Bernet, MD
Victor Bernet, MD 
Mayo Clinic

Member at Large

Dwight Vicks, III
Dwight Vicks, IIICo-Founder
Vicks Printing

Chief Financial Officer

Patrick Fiorenza, PhD
Patrick Fiorenza, PhD 
International Thyroid Oncology Group

Chief Executive Officer